L-carnitine + synbiotic co-supplementation led to a significantly greater reduction in atherogenic-indices including atherogenic-index-of-plasma (AIP), Castellis-risk-index-I (CRI-I), Castellis-risk-index-II (CRI-II), atherogenic-coefficient (AC), lipoprotein-combine index (LCI), systolic blood pressure (SBP), fat-mass (FM) weight/percent, visceral-adiposity index (VAI), waste-to-height ratio (WHtR), body-adiposity index (BAI), and appetite sensation scores compared to L-carnitine mono-therapy
McLendon, P
10.3389/fphys.2021.645342 154 KinneyJ
30-day money-back guarantee A 30-day money-back guarantee on a medication that requires consistent use to show results is a reasonable commitment
However, during the early 2000s, Mugesh et al
Heart Rate Changes: Unlike some older loss medications , triple agonists can cause a modest increase in heart rate (5-10 bpm), which requires monitoring in patients with pre-existing heart disease